However, tumors frequently contain additional co-occurring mutations in genes like tumor protein p53 (TP53), serine/threonine kinase 11 (STK11), and Kelch-like ECH-associated protein 1 (KEAP1), which may affect tumor growth, immune evasion, and treatment response. The gene discussed is STK11; the disease is neoplasm.